Search Results - "Waxman, I M"

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors by Zhao, X., Suryawanshi, S., Hruska, M., Feng, Y., Wang, X., Shen, J., Vezina, H.E., McHenry, M.B., Waxman, I.M., Achanta, A., Bello, A., Roy, A., Agrawal, S.

“…Nivolumab 3 mg/kg every 2 weeks (Q2W) has shown benefit versus the standard of care in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma…”
Get full text

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study by Long, G.V., Atkinson, V., Ascierto, P.A., Robert, C., Hassel, J.C., Rutkowski, P., Savage, K.J., Taylor, F., Coon, C., Gilloteau, I., Dastani, H.B., Waxman, I.M., Abernethy, A.P.

“…Nivolumab has shown significant survival benefit and a favorable safety profile compared with dacarbazine chemotherapy among treatment-naïve patients with…”
Get full text

The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients by Le Gall, J B, Milone, M C, Waxman, I M, Shaw, L M, Harrison, L, Duffy, D, van de Ven, C, Militano, O, Geyer, M B, Morris, E, Bhatia, M, Satwani, P, George, D, Garvin, J H, Bradley, M B, Schwartz, J, Baxter-Lowe, L A, Cairo, M S

“…Intravenous BU divided four times daily (q6 h) has been shown to be safe and effective in pediatric allo-SCT recipients. Though less frequent dosing is…”
Get full text

Assessment of nivolumab (Nivo) benefit-risk profile from a 240-mg flat dose versus a 3-mg/kg dosing regimen in patients (Pts) with solid tumors by Zhao, X., Suryawanshi, S., Hruska, M., Feng, Y., Wang, X., Shen, J., McHenry, B., Waxman, I.M., Achanta, A., Bello, A., Roy, A., Agrawal, S.

Get full text

Variability in Pediatric injury patterns by age and ethnic groups in Israel by Savitsky, Bella, Aharonson-Daniel, Limor, Giveon, Adi, The Israel Trauma Group, Peleg, Kobi

“…Background. In Israel, nearly 10,000 children are hospitalized due to injury every year. Objectives. To define injury patterns in subgroups of the pediatric…”
Get full text